Get started
Author

Corey Adams

Observed name: Adams, Corey
Institution: NoNO (Canada)
ORCID: 0009-0001-3645-3154
Observed ORCID: 0009-0001-3645-3154
OpenAlex ID: A5014966807
Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial
2020 · Michael D Hill, Mayank Goyal, et al. · The Lancet · 673
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial
2025 · Michael D Hill, Mayank Goyal, et al. · The Lancet · 75
Efficacy and safety of intravenous nerinetide initiated by paramedics in the field for acute cerebral ischaemia within 3 h of symptom onset (FRONTIER): a phase 2, multicentre, randomised, double-blind, placebo-controlled study
2025 · Jim Christenson, Michael D Hill, et al. · The Lancet · 49
Safety and efficacy of nerinetide in patients with acute ischaemic stroke enrolled in the early window: a post-hoc meta-analysis of individual patient data from three randomised trials
2025 · Michael Tymianski, Michael D Hill, et al. · The Lancet Neurology · 43
Partial Oral Versus Intravenous Antibiotic Therapy for Endocarditis With Management by a Multidisciplinary Team: A Retrospective Cohort Study
2025 · Sami El-Dalati, Bennett Collis, et al. · Open Forum Infectious Diseases · 6
PDF
Health economic impact of Nerinetide in addition to mechanical thrombectomy without concurrent alteplase
2023 · Johanna M Ospel, Corey Adams, et al. · Interventional Neuroradiology · 2
Safety and Efficacy of Nerinetide at Year 1 in Participants Enrolled in ESCAPE‐NEXT: A Multicenter, Double‐Blind, Randomized Controlled Trial
2026 · Corey Adams, Kathy Heard, et al. · Journal of the American Heart Association · 1
Minimal Sufficient Balance Randomization and Site-Specific Treatment Allocation Imbalance in Multicenter Acute Stroke Trials
2026 · Timofei Biziaev, Michael D. Hill, et al. · Stroke
Abstract Number: Esoc2026a2477 Method of Consent and Time to Randomization in the Escape Next Trial
2026 · Tina Wu, Marie-Jo Abdul-Hay, et al. · European Stroke Journal
Abstract Number: Esoc2026a2426 Consent Form Variability in the Escape Next Trial
2026 · Marie-Jo Abdul-Hay, Tina Wu, et al. · European Stroke Journal
Cytoprotective agents in stroke: Still uncertainty in the next frontier
2024 · A. Zohaib Siddiqi, Nima Kashani, et al. · Journal of Stroke and Cerebrovascular Diseases
PDF
Abstract TP394: Senior Clinical Project Leader
2019 · Davis Chau, Dave Garman, et al. · Stroke
Works count: 14
Citation count: 849
H-index: 5
I10-index: 4
Year
Topic
Type